EUROAPI announces today the implementation of an initial 4-year manufacturing agreement with Novéal, an integral part of the L’Oréal Group with a focus on developing eco-responsible processes and guaranteeing exclusive, high-performance ingredients to sustainably meet the beauty needs of consumers around the world.

As part of this collaboration, EUROAPI will develop and industrialize the manufacturing process of innovative cosmetic ingredients through its Contract Development and Manufacturing Organization (CDMO) activity. This agreement encompasses several projects, the first of which will take place at EUROAPI’s Frankfurt site with a dedicated line of complex chemistry production.

“Cosmetics is a new and growing segment for EUROAPI’s CDMO business. Signing this manufacturing agreement with Novéal demonstrates our ability to adapt to cosmetics’ short timelines and regulatory and quality requirements,” said Cécile Maupas, Chief CDMO Officer of EUROAPI. “This multi-million-euro contract is a strong recognition of EUROAPI’s broad panel of technologies and capacities to respond to the increasing demand across different modalities, and to guarantee full business continuity for cosmetic ingredients.”

The CDMO activity is a strategic priority for EUROAPI. Since the creation of its dedicated CDMO business development team in 2021, EUROAPI has achieved substantial results and doubled the number of customers in only one year, with 79 projects won from preclinical phase up to commercial supply.